{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:39:39Z","timestamp":1788489579436,"version":"build-2803163510"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":453,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000042","name":"Amgen, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000042","name":"Amgen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Limited data are available that evaluate the efficacy of renin-angiotensin system inhibitor (RASI) dose-reduction in older adults with heart failure with reduced ejection fraction following a heart failure hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We examined a 5% random sample of Medicare beneficiaries with prescription coverage who were discharged to home following a hospitalization for heart failure with reduced ejection fraction between 1 January 2007 and 30 June 2018 and were treated with RASI prior to hospitalization. We classified patients into three mutually exclusive groups based on RASI dosage before (prescription fills up to 90 days prior to) and after a hospitalization (prescription fills up to 365 days that were most proximate to the discharge date as possible)\u2014same\/increased dose, dose-reduction, and discontinuation. We examined associations between RASI prescribing patterns and outcomes (mortality and all-cause readmission at 30 days and 1 year) using Cox proportional hazards models. Among 12 794 unique older adults, 36.8% experienced a RASI reduction following their hospitalization for HFrEF\u201415.7% had a dose-reduction and 21.1% had a discontinuation. Neither dose-reduction nor discontinuation was associated with 30-day mortality. Discontinuation was associated 1-year mortality, 30-day all-cause readmission, and 1-year all-cause readmission, whereas dose-reduction was not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RASI dose-reduction occurs in 1 out of 7 HF hospitalizations. In contrast to RASI discontinuation, RASI dose-reduction was not associated with adverse short or long-term outcomes. These findings indicate that RASI dose-reduction is preferred over RASI discontinuation in selected situations where RASI reduction is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14953","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:24:50Z","timestamp":1721363090000},"page":"3862-3871","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reductions in Renin-Angiotensin System Inhibitors Following Hospitalization for Heart Failure"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-3737","authenticated-orcid":false,"given":"Parag","family":"Goyal","sequence":"first","affiliation":[{"name":"Department of Medicine, Weill Cornell Medicine , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham , Birmingham, AL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer D.","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Medicine, Weill Cornell Medicine , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Rosenson","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mount Sinai , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily B.","family":"Levitan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Alabama at Birmingham , Birmingham, AL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"2026012113122480000_ehf214953-bib-0001","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2026012113122480000_ehf214953-bib-0002","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/j.ahj.2004.09.015","article-title":"The American Heart Association Get With The Guidelines program","volume":"148","author":"Smaha","year":"2004","journal-title":"Am Heart J"},{"key":"2026012113122480000_ehf214953-bib-0003","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2018.06.011","article-title":"Initiation, continuation, switching, and withdrawal of heart failure medical therapies during hospitalization","volume":"7","author":"Bhagat","year":"2019","journal-title":"JACC Heart Fail."},{"key":"2026012113122480000_ehf214953-bib-0004","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/jgs.12504","article-title":"Adverse drug events after hospital discharge in older adults: Types, severity, and involvement of beers criteria medications","volume":"61","author":"Kanaan","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"2026012113122480000_ehf214953-bib-0005","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/gerona\/glz224","article-title":"Measuring frailty in administrative claims data: Comparative performance of four claims-based frailty measures in the U.S. Medicare data","volume":"75","author":"Kim","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026012113122480000_ehf214953-bib-0006","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/gerona\/gly197","article-title":"Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study","volume":"74","author":"Kim","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026012113122480000_ehf214953-bib-0007","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10742-010-0060-4","article-title":"Identifying types of nursing facility stays using Medicare claims data: An algorithm and validation","volume":"1","author":"Yun","year":"2010","journal-title":"Health Serv Outcomes Res Methodol"},{"key":"2026012113122480000_ehf214953-bib-0008","first-page":"S212","article-title":"Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors","volume":"21","author":"Epstein","year":"2015","journal-title":"Am J Manag Care"},{"key":"2026012113122480000_ehf214953-bib-0009","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: A comparative analysis of three randomised controlled trials","volume":"396","author":"Vaduganathan","year":"2020","journal-title":"Lancet"},{"key":"2026012113122480000_ehf214953-bib-0010","doi-asserted-by":"crossref","DOI":"10.1161\/circ.132.suppl_3.18410","article-title":"Prescriptions for and use of \u03b2-blocker following heart failure hospitalization: The REasons for geographic and racial differences in stroke (REGARDS) study (abstract)","volume":"132","author":"Levitan","year":"2015","journal-title":"Circulation"},{"key":"2026012113122480000_ehf214953-bib-0011","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.jacc.2019.02.015","article-title":"Titration of medical therapy for heart failure with reduced ejection fraction","volume":"73","author":"Greene","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012113122480000_ehf214953-bib-0012","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/gerona\/61.5.511","article-title":"Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay","volume":"61","author":"Hanlon","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026012113122480000_ehf214953-bib-0013","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.006977","article-title":"Polypharmacy in older adults hospitalized for heart failure","volume":"13","author":"Unlu","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2026012113122480000_ehf214953-bib-0014","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jchf.2021.12.004","article-title":"Frailty, guideline-directed medical therapy, and outcomes in HFrEF: From the GUIDE-IT trial","volume":"10","author":"Khan","year":"2022","journal-title":"JACC Heart Fail."},{"key":"2026012113122480000_ehf214953-bib-0015","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s40266-022-00957-8","article-title":"The prevalence of adverse drug reactions and adverse drug events from heart failure medications in frail older adults: A systematic review","volume":"39","author":"Duong","year":"2022","journal-title":"Drugs Aging"},{"key":"2026012113122480000_ehf214953-bib-0016","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1161\/CIRCULATIONAHA.122.061754","article-title":"Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: A prespecified analysis of the DELIVER trial","volume":"146","author":"Butt","year":"2022","journal-title":"Circulation"},{"key":"2026012113122480000_ehf214953-bib-0017","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jchf.2018.02.015","article-title":"African Americans are less likely to receive care by a cardiologist during an intensive care unit admission for heart failure","volume":"6","author":"Breathett","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2026012113122480000_ehf214953-bib-0018","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006214","article-title":"Identification of racial inequities in access to specialized inpatient heart failure care at an Academic Medical Center","volume":"12","author":"Eberly","year":"2019","journal-title":"Circ Heart Fail"},{"key":"2026012113122480000_ehf214953-bib-0019","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.23080","article-title":"Racial and sex inequities in the use of and outcomes after left ventricular assist device implantation among Medicare beneficiaries","volume":"5","author":"Cascino","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026012113122480000_ehf214953-bib-0020","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.jacc.2012.12.038","article-title":"Heart failure-associated hospitalizations in the United States","volume":"61","author":"Blecker","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/6\/3862\/64517065\/eschf_11_6_3862.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/6\/3862\/64517065\/eschf_11_6_3862.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:14:22Z","timestamp":1769019262000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/6\/3862\/8269384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,7,19]]},"published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14953","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,7,19]]},"assertion":[{"value":"2023-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}